Penn Medicine

Hospital


Location: Philadelphia, PA, United States (USA) (US) US

ISNI: 0000000404540768

ROR: https://ror.org/04h81rw26

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment (2026) Biller BM, Casagrande A, Elenkova A, Boguszewski CL, Jallad RS, Hu B, Hubina E, et al. Journal article Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis (2026) Oertel M, Dabaja B, Görlich D, Thomas BR, Sim V, Johnstone P, Hashmi A, et al. Journal article The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD (2025) Akahoshi Y, Portelli J, Katsivelos N, Louloudis IE, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, et al. Journal article Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC (2025) Akahoshi Y, Inamoto Y, Spyrou N, Nakasone H, Diniz MA, Asada N, Ayuk F, et al. Journal article Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article, Letter BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2-Breast Cancer Treated with Endocrine Therapy with or Without Palbociclib: A Secondary PENELOPE-B Study Analysis (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group (2025) Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, Hogan W, et al. Journal article Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine (2024) Gadelha MR, Casagrande A, Strasburger CJ, Bidlingmaier M, Snyder PJ, Guitelman MA, Boguszewski CL, et al. Journal article The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD (2024) DeFilipp Z, Kim HT, Spyrou N, Katsivelos N, Kowalyk S, Eng G, Kasikis S, et al. Journal article
1 2 3 4